Literature DB >> 2411380

Fibronectin patterns in hepatocellular carcinoma and its clinical significance.

J Jagirdar, K G Ishak, M Colombo, C Brambilla, F Paronetto.   

Abstract

Fibronectin, a high molecular weight glycoprotein component of the extracellular matrix, was localized extracellularly and intracellularly in the nuclei and the cytoplasm of hepatocellular carcinomas (HCC) by the use of the biotin-avidin method on paraffin-embedded, pepsin-treated tissue. The specificity of the staining was confirmed by absorbing the antibodies with purified fibronectin. Twenty HCC were investigated (7 were autopsy specimens and 13 biopsy and surgical specimens). The fibronectin was either increased or decreased. When increased the fibronectin consisted of thin or thick feathery strands and was either pericellular, sinusoidal, periglandular, or stromal. Marked increase of fibronectin was seen in fibrolamellar HCC, clear cell HCC, and encapsulated HCC, correlating with the better prognosis. Decreased fibronectin was seen in two undifferentiated HCC. HCC obtained at autopsy displayed nuclear and cytoplasmic fibronectin staining. Nuclear fibronectin may be an expression of the DNA binding ability of fibronectin which becomes demonstrable in cells with increased membrane permeability.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411380     DOI: 10.1002/1097-0142(19851001)56:7<1643::aid-cncr2820560730>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.

Authors:  Elana P Simon; Catherine A Freije; Benjamin A Farber; Gadi Lalazar; David G Darcy; Joshua N Honeyman; Rachel Chiaroni-Clarke; Brian D Dill; Henrik Molina; Umesh K Bhanot; Michael P La Quaglia; Brad R Rosenberg; Sanford M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-21       Impact factor: 11.205

2.  Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.

Authors:  Brian I Carr; Siddhartha Kar; Meifang Wang; Ziqiu Wang
Journal:  Cell Biol Int       Date:  2007-03-19       Impact factor: 3.612

3.  A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.

Authors:  Raghothama Chaerkady; H C Harsha; Anuradha Nalli; Marjan Gucek; Perumal Vivekanandan; Javed Akhtar; Robert N Cole; Jessica Simmers; Richard D Schulick; Sujay Singh; Michael Torbenson; Akhilesh Pandey; Paul J Thuluvath
Journal:  J Proteome Res       Date:  2008-08-21       Impact factor: 4.466

4.  Immunohistochemical study of fibronectin, lysozyme, and alpha-fetoprotein (AFP) in human hepatocellular carcinoma.

Authors:  H Okushin; G Yamada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-02

5.  Serum fibronectin distinguishes the early stages of hepatocellular carcinoma.

Authors:  Hyunsoo Kim; JiYoung Park; Yongkang Kim; Areum Sohn; Injun Yeo; Su Jong Yu; Jung-Hwan Yoon; Taesung Park; Youngsoo Kim
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

6.  Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein.

Authors:  Young-Joo Jin; Habtamu Minassie Aycheh; Seonggyun Han; John Chamberlin; Jaehang Shin; Seyoun Byun; Younghee Lee
Journal:  BMC Med Genomics       Date:  2020-12-28       Impact factor: 3.063

7.  Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment.

Authors:  Sun Ah Kim; Eun Ju Cho; Sungyoung Lee; Young Youn Cho; Boram Kim; Jung-Hwan Yoon; Taesung Park
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

8.  Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.

Authors:  Maya S Krishnan; Anand Rajan Kd; Jangho Park; Vinodhini Arjunan; Fernando Jose Garcia Marques; Abel Bermudez; Olivia A Girvan; Nam S Hoang; Jun Yin; Mindie H Nguyen; Nishita Kothary; Sharon Pitteri; Dean W Felsher; Renumathy Dhanasekaran
Journal:  Hepatology       Date:  2021-05-08       Impact factor: 17.298

Review 9.  Fibronectin in Cancer: Friend or Foe.

Authors:  Tsung-Cheng Lin; Cheng-Han Yang; Li-Hsin Cheng; Wen-Tsan Chang; Yuh-Rong Lin; Hung-Chi Cheng
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.